Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BrainXell, founded in 2015 by stem cell neuroscience pioneer Dr. Su Chun Zhang, develops high purity human neurons from iPSCs to support drug discovery and neurological research. Using proprietary directed differentiation technology, we partner with biotech and pharma companies to create specialized neuronal models for disease and screening applications. In 2022, BrainXell Therapeutics was launched to advance novel cell therap...
BrainXell, founded in 2015 by stem cell neuroscience pioneer Dr. Su Chun Zhang, develops high purity human neurons from iPSCs to support drug discovery and neurological research. Using proprietary directed differentiation technology, we partner with biotech and pharma companies to create specialized neuronal models for disease and screening applications. In 2022, BrainXell Therapeutics was launched to advance novel cell therapies, with programs in Parkinson’s disease and spinal cord injury aimed at transforming care for patients with neurological disorders.

List your booth number for exhibitions, ask us